Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 110
interventional 73
Observational 34
Registry 3

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug|placebo 28
Drug 18
Device 8
Other 6
Drug|Other 2
Behavioral|Drug 1
Biological 1
Biological|Other 1
Biological|placebo 1
Device|Drug|Procedure 1
Device|Other 1
Device|Procedure 1
Diagnostic Test|Drug|Other|placebo 1
Drug|Procedure 1
Drug|Procedure|Radiation 1
Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 58
Switzerland 4
Germany 3
United States|Canada 2
Italy 1
United States|Australia|Belgium|Canada|France|Germany|Italy|Netherlands|Spain|United Kingdom 1
United States|Australia|Canada|United Kingdom 1
United States|Australia|Netherlands 1
United States|Belgium|Canada|Germany|Spain|Switzerland 1
United States|Canada|Switzerland 1

Sites per Study

Site_count Study_Count
1 48
2 2
3 1
4 3
5 1
7 1
9 1
14 1
17 1
20 1
21 1
23 1
29 1
30 1
36 1
37 1
45 1
53 1
56 1
62 1
75 1
77 1
81 1

Phase

Phase Study_Count
Phase 2 23
N/A 21
Phase 3 10
Phase 2/Phase 3 6
Phase 4 5
Phase 1 4
Early Phase 1 2
Phase 1/Phase 2 2

Number of Arms

Number_of_Arms Count_of_Studies
1 21
2 29
3 9
4 7
5 1
NA 6

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 3.0 5.00000 19.00 24 10.00000 26.0000 30.0 16.0
1st Qu. 6.5 24.00000 19.75 24 28.50000 55.0000 105.0 64.0
Median 10.0 25.00000 20.00 24 42.00000 98.0000 175.0 90.0
Mean 10.0 43.19048 25.00 24 50.59091 133.3333 183.5 79.8
3rd Qu. 13.5 50.00000 25.25 24 75.00000 202.5000 203.0 100.0
Max. 17.0 179.00000 41.00 24 106.00000 300.0000 425.0 129.0

Trial Group Type

group_type Group_Count
Experimental 79
Placebo Comparator 28
Active Comparator 23
Other 8
NA 6
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Parallel Assignment 41
Single Group Assignment 26
Crossover Assignment 4
Sequential Assignment 1
NA 1

Primary Purpose

primary_purpose Study_Count
Treatment 56
Diagnostic 6
Other 4
Basic Science 3
NA 2
Prevention 1
Supportive Care 1

Observational Studies

Studies by Country

Country Study_Count
United States 30
Finland|Romania 1
Israel|Italy 1
NA 1
Switzerland 1

Sites per Study

Site_count Study_Count
1 26
2 1
3 1
5 1
6 3
8 1
18 1

Enrollment Metrics

Measure Observational
Min 10.0000
1st Qu 30.2500
Median 92.5000
Mean 617.6471
3rd Qu 495.7500
Max 10000.0000

Observation Model

observational_model Study_Count
Cohort 14
Case-Control 7
Case-Only 6
Other 5
NA 2

Time Perspective

time_perspective Study_Count
Prospective 27
Other 3
Retrospective 3
Cross-Sectional 1

Registries

Studies by Country

Country Study_Count
United States 2
Spain 1

Sites per Study

Site_count Study_Count
1 1
2 2

Enrollment Metrics

Measure Registries
Min 88.0000
1st Qu 94.0000
Median 100.0000
Mean 229.3333
3rd Qu 300.0000
Max 500.0000

Registry Model

observational_model Study_Count
Cohort 2
Case-Only 1

Time Perspective

time_perspective Study_Count
Prospective 2
Cross-Sectional 1

Follow-up

target_duration Study_Count
1 Day 1
2 Years 1
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04322708 A Study of Antolimab (AK002) in Patients With Active Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT04322708 Recruiting Allakos, Inc. 2021-12-31
NCT04322604 A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis) https://ClinicalTrials.gov/show/NCT04322604 Recruiting Allakos, Inc. 2021-12-31
NCT03633617 Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT03633617 Recruiting Regeneron Pharmaceuticals 2022-04-22
NCT03342391 CEGIR 7808: Use of Unsedated Transnasal Esophagoscopy (TNE) to Monitor Dietary Management of Eosinophilic Esophagitis in Children https://ClinicalTrials.gov/show/NCT03342391 Recruiting Children’s Hospital Medical Center, Cincinnati 2020-07-31
NCT03320369 CEGIR 7809: Effect of Elemental Diet on Adult Patients With Eosinophilic Gastroenteritis https://ClinicalTrials.gov/show/NCT03320369 Recruiting Children’s Hospital Medical Center, Cincinnati 2019-09-01
NCT03305653 Use of Esophageal String Test to Understand Symptoms, Inflammation, and Function in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT03305653 Recruiting University of Colorado, Denver 2020-12-31
NCT03191864 Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT03191864 Active, not recruiting Adare Pharmaceuticals, Inc. 2019-11-08
NCT03078023 Sponge and Eosinophil Peroxidase (EPO) Staining https://ClinicalTrials.gov/show/NCT03078023 Recruiting Mayo Clinic 2021-03-01
NCT03029091 An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT03029091 Completed Children’s Hospital Medical Center, Cincinnati 2019-07-22
NCT02881372 EoE Food Desensitization https://ClinicalTrials.gov/show/NCT02881372 Recruiting The University of Texas Health Science Center, Houston 2020-05-31
NCT02778867 SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study https://ClinicalTrials.gov/show/NCT02778867 Completed Children’s Hospital Medical Center, Cincinnati 2019-04-17
NCT02736409 An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT02736409 Completed Shire 2019-11-04
NCT02722148 Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in Patients With Eosinophilic Esophagitis (IDiET) https://ClinicalTrials.gov/show/NCT02722148 Completed University of North Carolina, Chapel Hill 2018-04-30
NCT02610816 Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids https://ClinicalTrials.gov/show/NCT02610816 Completed Children’s Hospital Medical Center, Cincinnati 2018-05-16
NCT02605837 A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved https://ClinicalTrials.gov/show/NCT02605837 Completed Shire 2019-01-24
NCT02599558 Cytosponge and Dietary Therapy in EoE https://ClinicalTrials.gov/show/NCT02599558 Recruiting Mayo Clinic 2020-12-31
NCT02493335 Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02493335 Active, not recruiting Dr. Falk Pharma GmbH 2018-11-28
NCT02434029 Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02434029 Completed Dr. Falk Pharma GmbH 2016-08-04
NCT02379052 Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT02379052 Completed Regeneron Pharmaceuticals 2017-02-17
NCT02371941 Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02371941 Completed University of Tennessee 2017-07-31
NCT02353078 The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02353078 Completed Mayo Clinic 2016-12-31
NCT02280616 Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02280616 Completed Dr. Falk Pharma GmbH 2013-04-30
NCT02227836 Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02227836 Completed Mayo Clinic 2017-09-30
NCT02204150 Study to Image the Esophagus Using the OFDI Capsule https://ClinicalTrials.gov/show/NCT02204150 Completed Massachusetts General Hospital 2015-07-31
NCT02202590 Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus https://ClinicalTrials.gov/show/NCT02202590 Active, not recruiting Massachusetts General Hospital 2021-12-31
NCT02125851 Comparison of Esophageal Clearance Times of Oral Budesonide Preparations https://ClinicalTrials.gov/show/NCT02125851 Completed Walter Reed National Military Medical Center 2014-02-28
NCT02098473 Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02098473 Completed Celgene 2016-02-17
NCT02038894 Comparing Anesthetic Techniques in Children Having Esophagogastroduodenoscopies https://ClinicalTrials.gov/show/NCT02038894 Completed Children’s Hospital Medical Center, Cincinnati 2013-11-30
NCT02019758 Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02019758 Completed University of North Carolina, Chapel Hill 2018-05-31
NCT01999439 EoE(Eosinophilic Esophagitis) https://ClinicalTrials.gov/show/NCT01999439 Completed University of Michigan 2016-04-30
NCT01953575 Mucosal Impedance and Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT01953575 Completed Mayo Clinic 2019-06-10
NCT01846962 Dietetic Versus Topical Steroids for Pediatric Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT01846962 Completed Azienda Policlinico Umberto I 2013-04-30
NCT01642212 OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension https://ClinicalTrials.gov/show/NCT01642212 Completed Shire 2014-10-30
NCT01641913 Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients https://ClinicalTrials.gov/show/NCT01641913 Completed Mayo Clinic 2014-01-31
NCT01585103 Cytosponge Protocol IRB 11-006429 https://ClinicalTrials.gov/show/NCT01585103 Recruiting Mayo Clinic 2021-09-30
NCT01386112 Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT01386112 Completed Forest Laboratories 2012-10-31
NCT04281108 Efficacy and Safety APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2) https://ClinicalTrials.gov/show/NCT04281108 Recruiting Adare Pharmaceuticals, Inc. 2021-10-31
NCT04149470 Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE) https://ClinicalTrials.gov/show/NCT04149470 Recruiting University of Colorado, Denver 2021-12-31
NCT04069429 Radiation Dose in Humans From Orally Administered Tc99m-Heparin https://ClinicalTrials.gov/show/NCT04069429 Recruiting University of Utah 2020-12-31
NCT03245840 Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT03245840 Active, not recruiting Shire 2021-08-31
NCT03781596 EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone https://ClinicalTrials.gov/show/NCT03781596 Recruiting Walter Reed National Military Medical Center 2020-10-02
NCT03664960 An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis https://ClinicalTrials.gov/show/NCT03664960 Active, not recruiting Allakos, Inc. 2021-03-31
NCT03657771 A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT03657771 Recruiting Nemours Children’s Clinic 2020-09-30
NCT03656380 Mepo for EoE Study https://ClinicalTrials.gov/show/NCT03656380 Recruiting University of North Carolina, Chapel Hill 2020-12-31
NCT03496571 A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis https://ClinicalTrials.gov/show/NCT03496571 Completed Allakos, Inc. 2019-06-24
NCT03473977 Benralizumab for Eosinophilic Gastritis https://ClinicalTrials.gov/show/NCT03473977 Recruiting Children’s Hospital Medical Center, Cincinnati 2020-03-30
NCT03446118 MRI to Assess Fibrosis in Eosinophilic Esophagitis Patients https://ClinicalTrials.gov/show/NCT03446118 Recruiting Mayo Clinic 2021-01-15
NCT01056783 Proof of Concept Study of OC000459 in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT01056783 Completed Oxagen Ltd 2011-06-30
NCT01040598 Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model https://ClinicalTrials.gov/show/NCT01040598 Completed O & O Alpan LLC 2011-12-31
NCT01022970 Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT01022970 Completed Novartis 2012-02-29
NCT01016223 A Randomized Double Blind Placebo Controlled Study of the Effect of Swallowed Beclomethasone Dipropionate on Inflammatory Markers in Adult Patients With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT01016223 Completed Penn State University 2012-07-31
NCT00961233 Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT00961233 Completed University of North Carolina, Chapel Hill 2011-08-31
NCT00895817 Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00895817 Completed Walter Reed Army Medical Center 2010-10-31
NCT00880906 Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00880906 Completed Vanderbilt University Medical Center 2013-12-31
NCT02579876 Milk Patch for Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02579876 Completed Children’s Hospital of Philadelphia 2017-12-20
NCT00762073 Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00762073 Completed Shire 2010-04-30
NCT00728481 The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00728481 Completed Mayo Clinic 2010-12-31
NCT00638456 Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00638456 Completed University of California, San Diego 2009-09-30
NCT00635089 Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00635089 Completed Teva Pharmaceutical Industries 2012-01-31
NCT00538434 Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years https://ClinicalTrials.gov/show/NCT00538434 Completed Teva Pharmaceutical Industries 2009-10-31
NCT00523354 Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00523354 Completed Swiss EE Study Group 2007-09-30
NCT00511316 Trial of Montelukast in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00511316 Completed Mayo Clinic 2015-09-30
NCT00426283 A Study of Flovent in Patients With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00426283 Completed Children’s Hospital Medical Center, Cincinnati 2013-01-31
NCT00358449 Intravenous Mepolizumab In Children With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00358449 Completed GlaxoSmithKline 2008-11-25
NCT00275561 Topical Steroid Treatment for Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00275561 Completed Mayo Clinic 2010-04-30
NCT00274703 An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients https://ClinicalTrials.gov/show/NCT00274703 Completed GlaxoSmithKline 2007-03-31
NCT00271349 Budesonide for Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00271349 Completed Swiss EE Study Group 2008-07-31
NCT00266578 A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders https://ClinicalTrials.gov/show/NCT00266578 Completed Children’s Hospital Medical Center, Cincinnati 2006-11-30
NCT00266565 Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome https://ClinicalTrials.gov/show/NCT00266565 Completed Children’s Hospital Medical Center, Cincinnati 2012-07-31
NCT00148603 Montelukast in the Treatment of Duodenal Eosinophilia https://ClinicalTrials.gov/show/NCT00148603 Completed Children’s Mercy Hospital Kansas City NA
NCT00123656 Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT00123656 Completed University of Utah 2006-12-31
NCT00123630 A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab https://ClinicalTrials.gov/show/NCT00123630 Completed University of Utah 2010-01-31
NCT00084097 Omalizumab to Treat Eosinophilic Gastroenteritis https://ClinicalTrials.gov/show/NCT00084097 Completed National Institutes of Health Clinical Center (CC) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03312686 Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study https://ClinicalTrials.gov/show/NCT03312686 Recruiting Indiana University 2018-12-31
NCT03107819 Metabolomics for Biomarker Discovery in Children With EoE https://ClinicalTrials.gov/show/NCT03107819 Completed The University of Texas Health Science Center, Houston 2018-03-31
NCT02995395 Mucosal Impedance Balloon in Diagnosis and Treatment of Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT02995395 Recruiting Mayo Clinic 2021-01-05
NCT02897271 Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort https://ClinicalTrials.gov/show/NCT02897271 Active, not recruiting Children’s Hospital Medical Center, Cincinnati 2019-09-30
NCT02775045 Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02775045 Completed University of Wisconsin, Madison 2018-12-13
NCT02546219 a4b7 Integrin in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02546219 Completed Massachusetts General Hospital 2018-12-31
NCT02523118 OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages https://ClinicalTrials.gov/show/NCT02523118 Recruiting Children’s Hospital Medical Center, Cincinnati 2050-12-31
NCT02453126 Fibrostenotic Eosinophilic Esophagitis: Assessment Tools https://ClinicalTrials.gov/show/NCT02453126 Recruiting University of Colorado, Denver 2020-06-30
NCT02320981 Mucosal Impedance in Pediatric Population https://ClinicalTrials.gov/show/NCT02320981 Completed Vanderbilt University Medical Center 2016-09-30
NCT02190513 Prevalence of Eosinophilic Esophagitis in Children With Celiac Disease https://ClinicalTrials.gov/show/NCT02190513 Completed St. John Health System, Michigan 2013-06-30
NCT02072590 Improved Diagnostics of Celiac Disease in Children https://ClinicalTrials.gov/show/NCT02072590 Recruiting Tampere University Hospital 2022-12-31
NCT02008903 Esophageal String Test in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02008903 Recruiting University of Colorado, Denver 2020-06-30
NCT01988285 Risk Factors and Biomarkers for Diagnosis and Treatment of EoE https://ClinicalTrials.gov/show/NCT01988285 Enrolling by invitation University of North Carolina, Chapel Hill 2020-08-31
NCT01929824 Nasal Nitric Oxide Levels in Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT01929824 Completed Mayo Clinic 2017-09-25
NCT01897506 Assessing Risk of Food Insecurity Within Households of Children With Food Allergy https://ClinicalTrials.gov/show/NCT01897506 Completed Arkansas Children’s Hospital Research Institute 2015-12-31
NCT01865825 Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)? https://ClinicalTrials.gov/show/NCT01865825 Completed Mayo Clinic 2016-12-31
NCT01832324 Molecular Basis of Food Allergy https://ClinicalTrials.gov/show/NCT01832324 Active, not recruiting Children’s Hospital of Philadelphia 2027-12-31
NCT01631591 Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT01631591 Completed University of South Florida 2014-07-31
NCT01498497 A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021 https://ClinicalTrials.gov/show/NCT01498497 Completed Forest Laboratories 2013-04-30
NCT01382563 Registry for Eosinophilic Gastrointestinal Disorders (REGID) https://ClinicalTrials.gov/show/NCT01382563 Active, not recruiting Children’s Hospital Medical Center, Cincinnati 2050-12-31
NCT01323803 Eosinophilic Esophagitis Databank https://ClinicalTrials.gov/show/NCT01323803 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2016-02-29
NCT01921686 Morphological Markers of Gastroesophageal Reflux Disease (GERD) https://ClinicalTrials.gov/show/NCT01921686 Active, not recruiting Baylor College of Medicine 2014-09-30
NCT04416217 Eosinophilic Esophagitis Steroid Safety Study https://ClinicalTrials.gov/show/NCT04416217 Recruiting Rabin Medical Center 2025-12-31
NCT04309786 Somatization, Anxiety, and Disordered Sleep in Pediatric Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT04309786 Recruiting University of California, San Diego 2021-04-11
NCT03615950 Effects of Swallowed Steroids on Bone Density and Growth in Pediatric Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT03615950 Recruiting Arkansas Children’s Hospital Research Institute 2020-08-01
NCT03581838 Eating With Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT03581838 Completed Mayo Clinic 2019-07-23
NCT01170234 Exhaled Nitric Oxide as a Biomarker of Disease Activity in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT01170234 Completed Tufts Medical Center 2012-02-29
NCT03290482 Natural History of Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT03290482 Recruiting Mayo Clinic 2020-07-01
NCT03812575 The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT03812575 Recruiting The University of Texas Health Science Center, Houston 2020-02-28
NCT02434705 Food Antigen in Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT02434705 Recruiting Mayo Clinic 2021-05-31
NCT03980886 Characteristics and Inflammatory Markers in Children With Eosinophilic Esophagitis (EoE) https://ClinicalTrials.gov/show/NCT03980886 Recruiting University of California, San Diego 2028-12-17
NCT00667524 Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and Inflammation https://ClinicalTrials.gov/show/NCT00667524 Completed University of Bern 2009-03-31
NCT00267475 Data Bank for Eosinophilic Disorders https://ClinicalTrials.gov/show/NCT00267475 Completed Children’s Hospital Medical Center, Cincinnati 2012-12-31
NCT00256529 Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With Dysphagia https://ClinicalTrials.gov/show/NCT00256529 Completed University of Utah 2011-07-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03382678 CEGIR 7807: Validation of Online Cohort of EGID Patients Enrolled in RDCRN CEGIR Contact Registry https://ClinicalTrials.gov/show/NCT03382678 Enrolling by invitation Children’s Hospital Medical Center, Cincinnati 2019-08-01
NCT03822325 Inflammatory Mediators as Potential Non-Invasive Biomarkers in Subjects With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT03822325 Active, not recruiting Ann & Robert H Lurie Children’s Hospital of Chicago 2015-05-31
NCT03858426 Prospective Multicenter Nationwide Registry of Children With Eosinophilic Esophagitis https://ClinicalTrials.gov/show/NCT03858426 Recruiting Sociedad Espanola de Gastroenterologia, Hepatologia y Nutricion Pediatrica 2020-11-01